IL160780A0 - USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT - Google Patents

USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT

Info

Publication number
IL160780A0
IL160780A0 IL16078002A IL16078002A IL160780A0 IL 160780 A0 IL160780 A0 IL 160780A0 IL 16078002 A IL16078002 A IL 16078002A IL 16078002 A IL16078002 A IL 16078002A IL 160780 A0 IL160780 A0 IL 160780A0
Authority
IL
Israel
Prior art keywords
hcg
medicament
manufacture
Prior art date
Application number
IL16078002A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL160780A0 publication Critical patent/IL160780A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
IL16078002A 2001-09-12 2002-09-12 USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT IL160780A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307757 2001-09-12
PCT/GB2002/004158 WO2003022302A2 (fr) 2001-09-12 2002-09-12 Utilisation de hcg dans une hyperstimulation ovarienne controlee

Publications (1)

Publication Number Publication Date
IL160780A0 true IL160780A0 (en) 2004-08-31

Family

ID=8182261

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16078002A IL160780A0 (en) 2001-09-12 2002-09-12 USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT

Country Status (19)

Country Link
US (1) US7405197B2 (fr)
EP (1) EP1425032A2 (fr)
JP (1) JP2005501918A (fr)
KR (1) KR20040032954A (fr)
CN (1) CN100536912C (fr)
AR (1) AR036592A1 (fr)
BR (1) BR0212429A (fr)
CA (1) CA2457849A1 (fr)
EA (1) EA009330B1 (fr)
HR (1) HRP20040087A2 (fr)
IL (1) IL160780A0 (fr)
ME (1) MEP39208A (fr)
MX (1) MXPA04002256A (fr)
NO (1) NO20040991L (fr)
PL (1) PL369098A1 (fr)
RS (1) RS21004A (fr)
UA (1) UA82650C2 (fr)
WO (1) WO2003022302A2 (fr)
ZA (1) ZA200400835B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE416783T1 (de) * 2003-02-07 2008-12-15 Austria Wirtschaftsserv Gmbh Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US20150273020A1 (en) * 2007-05-11 2015-10-01 Lori R. Bernstein Hormone Normalization Therapy and Uses Therefor
ATE555721T1 (de) * 2009-04-23 2012-05-15 Hoffmann La Roche Verfahren und gerät zur ermittlung von empfehlungen für wirkstoffdosierungen anhand von messserien zumindest eines physiologischen parameters eines patienten
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012131306A1 (fr) 2011-03-31 2012-10-04 Ferring B.V. Préparation pharmaceutique
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
US20120265129A1 (en) * 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
BR112014001274A2 (pt) 2011-07-18 2017-04-18 Arts Biologics As composto de hormônio luteinizante, e, composição farmacêutica
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
MX2015004940A (es) 2012-10-18 2015-12-09 Neuralight Hd Llc Tratamiento de depresion y ptsd.
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
WO2018015497A2 (fr) 2016-07-21 2018-01-25 ObsEva S.A. Régimes posologiques d'antagonistes de l'ocytocine pour favoriser l'implantation d'embryons et prévenir les fausses couches
CA3035055A1 (fr) 2016-08-29 2018-03-08 Progena, Inc. Therapie par cellules souches somatiques autologues, procede de preparation controlable de composition therapeutique et procedure de traitement adaptatif de patient fiv
RU2646578C1 (ru) * 2017-02-13 2018-03-05 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ повышения эффективности имплантации эмбриона в естественном цикле зачатия и в протоколах вспомогательных репродуктивных технологий
CN109431647B (zh) * 2018-09-20 2020-10-30 华中农业大学 一种杂交水牛同期发情-定时输精的处理方法
EP4025207A1 (fr) 2019-09-03 2022-07-13 ObsEva S.A. Régimes posologiques d'antagonistes de l'ocytocine pour favoriser l'implantation d'embryons et prévenir les fausses couches
AU2021218895A1 (en) 2020-02-10 2022-09-15 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
TW202210096A (zh) * 2020-05-29 2022-03-16 荷蘭商菲林公司 治療不育症之方法
WO2026018221A1 (fr) 2024-07-18 2026-01-22 ReproNovo SA Compositions cristallines pour améliorer l'implantation d'embryons et leurs procédés d'utilisation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5705478A (en) * 1989-02-21 1998-01-06 Washington University Covalently linked β subunits of the glycoprotein hormones as antagonists
ES2247710T3 (es) * 1997-06-20 2006-03-01 Akzo Nobel N.V. Antagonista de gonadotropina.
ZA987497B (en) * 1997-09-08 1999-02-23 Akzo Nobel Nv Expression of gonadotropins in dictyostelium
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
CN1353617A (zh) * 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
EP1176976B2 (fr) 1999-05-07 2015-10-21 Laboratoires Serono SA Utilisation de lh administrée dans la phase folliculaire intermédiaire ou tardive pour le traitement de femmes anovulatoires
TR200401810T4 (tr) * 2000-01-27 2004-09-21 Applied Research Systems Ars Holding N. V. Kısırlık tedavisinde fsh'ın kullanılması

Also Published As

Publication number Publication date
UA82650C2 (uk) 2008-05-12
HK1067867A1 (zh) 2005-04-22
ZA200400835B (en) 2005-04-26
MXPA04002256A (es) 2004-07-23
EA200400427A1 (ru) 2004-08-26
EA009330B1 (ru) 2007-12-28
BR0212429A (pt) 2004-10-26
EP1425032A2 (fr) 2004-06-09
HRP20040087A2 (en) 2004-12-31
US20050065069A1 (en) 2005-03-24
CA2457849A1 (fr) 2003-03-20
AR036592A1 (es) 2004-09-22
KR20040032954A (ko) 2004-04-17
CN100536912C (zh) 2009-09-09
WO2003022302A2 (fr) 2003-03-20
RS21004A (sr) 2006-12-15
US7405197B2 (en) 2008-07-29
JP2005501918A (ja) 2005-01-20
CN1553808A (zh) 2004-12-08
WO2003022302A3 (fr) 2003-12-18
MEP39208A (en) 2011-02-10
PL369098A1 (en) 2005-04-18
NO20040991L (no) 2004-03-08

Similar Documents

Publication Publication Date Title
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
PL388076A1 (pl) Doustna postać dawki o przedłużonym uwalnianiu oksykodonu i jej zastosowanie
AU2002365120A8 (en) Medicaments
PL370563A1 (en) Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
GB0101153D0 (en) Improvement in the structure of a screw
IL160782A0 (en) USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
GB0102902D0 (en) Medicaments
GB0128415D0 (en) Medicaments
IL160781A0 (en) Use of lh in the manufacture of a medicament
IL160875A0 (en) The use of botulinus toxin for the manufacture of a medicament and a cosmetic
IL162507A (en) Use of ifnar2 mutants in the manufacture of medicaments
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof
GB0105469D0 (en) Medicaments
GB0128122D0 (en) Therapeutic use
GB0128138D0 (en) Pharmaceutical use
GB0123991D0 (en) New therapeutic use
GB0115182D0 (en) Medicaments
GB0128123D0 (en) Therapeutic use
GB0128128D0 (en) Therapeutic use
GB0128126D0 (en) Therapeutic use
GB0128089D0 (en) Therapeutic use
GB0128088D0 (en) Therapeutic use
GB0106802D0 (en) Therapeutic use
GB0128121D0 (en) Therapeutic use
GB0101470D0 (en) Medicament